Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
Holding IN:GLENMARK?
Track your performance easily
GLENMARK Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹766.65 - ₹1,830.05
Previous CloseN/A
Volume301.32K
Average Volume (3M)N/A
Market Cap
₹408.37B
Enterprise Value₹471.88B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.94
Next Earnings
Feb 13, 2025EPS Estimate
14.05Last Dividend Ex-Date
Sep 13, 2024Dividend Yield0.17%
Share Statistics
EPS (TTM)-31.01
Shares Outstanding282,188,140
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GLENMARK FAQ
What was Glenmark Pharmaceuticals Limited’s price range in the past 12 months?
Glenmark Pharmaceuticals Limited lowest stock price was ₹766.65 and its highest was ₹1830.05 in the past 12 months.
What is Glenmark Pharmaceuticals Limited’s market cap?
Glenmark Pharmaceuticals Limited’s market cap is ₹408.37B.
When is Glenmark Pharmaceuticals Limited’s upcoming earnings report date?
Glenmark Pharmaceuticals Limited’s upcoming earnings report date is Feb 13, 2025 which is in 13 days.
How were Glenmark Pharmaceuticals Limited’s earnings last quarter?
Glenmark Pharmaceuticals Limited released its earnings results on Nov 14, 2024. The company reported ₹12.55 earnings per share for the quarter, missing the consensus estimate of ₹14.7 by -₹2.15.
Is Glenmark Pharmaceuticals Limited overvalued?
According to Wall Street analysts Glenmark Pharmaceuticals Limited’s price is currently Overvalued.
Does Glenmark Pharmaceuticals Limited pay dividends?
Glenmark Pharmaceuticals Limited pays a Annually dividend of ₹2.5 which represents an annual dividend yield of 0.17%. See more information on Glenmark Pharmaceuticals Limited dividends here
What is Glenmark Pharmaceuticals Limited’s EPS estimate?
Glenmark Pharmaceuticals Limited’s EPS estimate is 14.05.
How many shares outstanding does Glenmark Pharmaceuticals Limited have?
Glenmark Pharmaceuticals Limited has 282,188,140 shares outstanding.
What happened to Glenmark Pharmaceuticals Limited’s price movement after its last earnings report?
Glenmark Pharmaceuticals Limited reported an EPS of ₹12.55 in its last earnings report, missing expectations of ₹14.7. Following the earnings report the stock price went down -0.442%.
Which hedge fund is a major shareholder of Glenmark Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in IN:GLENMARK
---
Technical Analysis
Aurobindo Pharma Ltd
―
Cipla Ltd
―
Dr. Reddy's Laboratories Ltd.
―
Lupin Limited
―
Sun Pharmaceutical Industries Limited
―
---